TNDM

Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration....

+See More

Here we provide our AYA proprietary alpha stock signals for all premium members on our AYA fintech network platform. Specifically, a high Fama-French multi-factor dynamic conditional alpha suggests that the stock is likely to consistently outperform the broader stock market benchmarks such as S&P 500, Dow Jones, Nasdaq, Russell 3000, MSCI USA, and MSCI World etc. Since March 2023, our proprietary alpha stock signals retain U.S. Patent and Trademark Office (USPTO) fintech patent protection, approval, and accreditation for 20 years. Our homepage and blog articles provide more details on this proprietary alpha stock market investment model with robust long-term historical backtest evidence.

Sharpe-Lintner-Black CAPM alpha (Premium Members Only) Fama-French (1993) 3-factor alpha (Premium Members Only) Fama-French-Carhart 4-factor alpha (Premium Members Only) Fama-French (2015) 5-factor alpha (Premium Members Only) Fama-French-Carhart 6-factor alpha (Premium Members Only) Dynamic conditional 6-factor alpha (Premium Members Only) Last update: Saturday 1 November 2025